Lesniak MS - Search Results

1

Lesniak MS. Lesniak MS. Expert Rev Neurother. 2006 Apr;6(4):479-88. doi: 10.1586/14737175.6.4.479. Expert Rev Neurother. 2006. PMID: 16623647 Review.

2

Immunotherapy for malignant glioma: current approaches and future directions.

Sikorski CW, Lesniak MS. Sikorski CW, et al. Among authors: lesniak ms. Neurol Res. 2005 Oct;27(7):703-16. doi: 10.1179/016164105X49481. Neurol Res. 2005. PMID: 16197807 Review.

3

Brain tumors: controversies and challenges in management.

Lesniak MS. Lesniak MS. Expert Rev Neurother. 2005 Nov;5(6 Suppl):1-2. doi: 10.1586/14737175.5.6.S1. Expert Rev Neurother. 2005. PMID: 16274264 No abstract available.

4

Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletions.

Sonabend AM, Lesniak MS. Sonabend AM, et al. Among authors: lesniak ms. Expert Rev Neurother. 2005 Nov;5(6 Suppl):S25-32. doi: 10.1586/14737175.5.6.S25. Expert Rev Neurother. 2005. PMID: 16274268 Review.

5

Surgical management of high-grade gliomas.

Hsieh JC, Lesniak MS. Hsieh JC, et al. Among authors: lesniak ms. Expert Rev Neurother. 2005 Nov;5(6 Suppl):S33-9. doi: 10.1586/14737175.5.6.S33. Expert Rev Neurother. 2005. PMID: 16274269 Review.

6

Targeted gene therapy to antigen-presenting cells in the central nervous system using hematopoietic stem cells.

Lesniak MS, Kelleher E, Pardoll D, Cui Y. Lesniak MS, et al. Neurol Res. 2005 Dec;27(8):820-6. doi: 10.1179/016164105X49454. Neurol Res. 2005. PMID: 16354542

7

Conditionally replicative adenoviral vectors for malignant glioma.

Sonabend AM, Ulasov IV, Lesniak MS. Sonabend AM, et al. Among authors: lesniak ms. Rev Med Virol. 2006 Mar-Apr;16(2):99-115. doi: 10.1002/rmv.490. Rev Med Virol. 2006. PMID: 16416455 Review.

8

Targeted therapy for malignant glioma: neural stem cells.

Lesniak MS. Lesniak MS. Expert Rev Neurother. 2006 Jan;6(1):1-3. doi: 10.1586/14737175.6.1.1. Expert Rev Neurother. 2006. PMID: 16466305 Review. No abstract available.

9

Oncolytic adenoviral therapy for glioblastoma multiforme.

Sonabend AM, Ulasov IV, Han Y, Lesniak MS. Sonabend AM, et al. Among authors: lesniak ms. Neurosurg Focus. 2006 Apr 15;20(4):E19. Neurosurg Focus. 2006. PMID: 16709024 Review.

10

CD46 represents a target for adenoviral gene therapy of malignant glioma.

Ulasov IV, Tyler MA, Zheng S, Han Y, Lesniak MS. Ulasov IV, et al. Among authors: lesniak ms. Hum Gene Ther. 2006 May;17(5):556-64. doi: 10.1089/hum.2006.17.556. Hum Gene Ther. 2006. PMID: 16716112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters